Mitochondria and ageing
MOTS-c
Editorial audit: October 15, 2026 · draft; scientific, medical and translation review pending
01What is reported
MOTS-c is described in exercise, insulin-sensitivity and metabolic combinations. Community injection cycles extend beyond what an endogenous measurement can establish.
02Proposed rationale
AMPK-related biology and mitochondrial signaling motivate interest. Endogenous associations and administering an external peptide are different interventions.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
03What the research shows
Important findings include experimental models and human exercise-related observations. These do not validate the book’s repeated injection cycle in healthy users.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
04Limits and unknowns
Do not infer improved performance, long-term metabolic benefit or longevity from a pathway diagram or circulating peptide association.
05Questions to ask about the product
Is the material MOTS-c itself, a modified analogue, or an incompletely identified product? Those exposures cannot be pooled automatically.
06Open research question
Which outcomes are feasible to measure consistently without changing treatment or encouraging exposure for the sake of data?
Primary and regulatory references
- 1.